Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tierra Biosciences is a synthetic biology company that has developed a high-throughput, cell-free protein synthesis platform. Based in San Leandro, California, the company aims to transform protein discovery by moving away from traditional, slow, cell-based manufacturing methods. Their proprietary Tierra Protein Platform allows researchers to submit protein sequences digitally and receive synthesized proteins in a fraction of the time required by conventional methods. The platform integrates artificial intelligence with automated liquid handling to optimize protein expression and stability. By providing protein-on-demand, Tierra supports pharmaceutical and biotech partners in rapidly screening thousands of candidates for therapeutic and industrial applications. The company is backed by prominent investors including Material Impact and Prosus Ventures, reflecting its role as a key infrastructure provider in the bio-economy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tierra Technologies.